Literature DB >> 25048123

Antigen-Antibody Interaction Database (AgAbDb): a compendium of antigen-antibody interactions.

Urmila Kulkarni-Kale1, Snehal Raskar-Renuse, Girija Natekar-Kalantre, Smita A Saxena.   

Abstract

Antigen-Antibody Interaction Database (AgAbDb) is an immunoinformatics resource developed at the Bioinformatics Centre, University of Pune, and is available online at http://bioinfo.net.in/AgAbDb.htm. Antigen-antibody interactions are a special class of protein-protein interactions that are characterized by high affinity and strict specificity of antibodies towards their antigens. Several co-crystal structures of antigen-antibody complexes have been solved and are available in the Protein Data Bank (PDB). AgAbDb is a derived knowledgebase developed with an objective to compile, curate, and analyze determinants of interactions between the respective antigen-antibody molecules. AgAbDb lists not only the residues of binding sites of antigens and antibodies, but also interacting residue pairs. It also helps in the identification of interacting residues and buried residues that constitute antibody-binding sites of protein and peptide antigens. The Antigen-Antibody Interaction Finder (AAIF), a program developed in-house, is used to compile the molecular interactions, viz. van der Waals interactions, salt bridges, and hydrogen bonds. A module for curating water-mediated interactions has also been developed. In addition, various residue-level features, viz. accessible surface area, data on epitope segment, and secondary structural state of binding site residues, are also compiled. Apart from the PDB numbering, Wu-Kabat numbering and explicit definitions of complementarity-determining regions are provided for residues of antibodies. The molecular interactions can be visualized using the program Jmol. AgAbDb can be used as a benchmark dataset to validate algorithms for prediction of B-cell epitopes. It can as well be used to improve accuracy of existing algorithms and to design new algorithms. AgAbDb can also be used to design mimotopes representing antigens as well as aid in designing processes leading to humanization of antibodies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25048123     DOI: 10.1007/978-1-4939-1115-8_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Understanding differences between synthetic and natural antibodies can help improve antibody engineering.

Authors:  Anat Burkovitz; Yanay Ofran
Journal:  MAbs       Date:  2015-12-14       Impact factor: 5.857

Review 2.  Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies.

Authors:  Rahmad Akbar; Habib Bashour; Puneet Rawat; Philippe A Robert; Eva Smorodina; Tudor-Stefan Cotet; Karine Flem-Karlsen; Robert Frank; Brij Bhushan Mehta; Mai Ha Vu; Talip Zengin; Jose Gutierrez-Marcos; Fridtjof Lund-Johansen; Jan Terje Andersen; Victor Greiff
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

3.  An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinants.

Authors:  Johnathan D Guest; Thom Vreven; Jing Zhou; Iain Moal; Jeliazko R Jeliazkov; Jeffrey J Gray; Zhiping Weng; Brian G Pierce
Journal:  Structure       Date:  2021-02-03       Impact factor: 5.871

4.  AllerBase: a comprehensive allergen knowledgebase.

Authors:  Kiran Kadam; Rajiv Karbhal; V K Jayaraman; Sangeeta Sawant; Urmila Kulkarni-Kale
Journal:  Database (Oxford)       Date:  2017-01-01       Impact factor: 3.451

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.